Provella™ helps keep feminine health in balance.*
Many women are at risk of suffering from unbalanced gastrointestinal (GI) or vaginal flora. Factors that may contribute to this imbalance include antibiotic use, changes in hormone levels, spermicides, and diet.1,2 Provella™ is a unique probiotic supplement specifically designed for women to support GI and vaginal health.*
6 bacterial strains support feminine health.
Provella™ contains a proprietary blend of 6 bacterial strains chosen specifically for maximum benefit to women.* The strains included are:
- Lactobacillus acidophilus
- Lactobacillus plantarum
- Lactobacillus rhamnosus
- Lactobacillus fermentum
- Lactobacillus reuteri
- Bifidobacterium bifidum
Provella™ features a patented controlled-release technology.
It has been estimated that as few as 20%-40% of certain probiotic bacteria survive passage through the gut.3 Stomach acid is a major threat to probiotic survival.3
Provella™ is formulated using a patented controlled-release technology that helps protect probiotics from harsh stomach acid and is designed to ensure that live organisms reach the intestines where they can begin working.4,5
Convenient to take and to find.
Provella™ should be taken once daily by mouth to promote digestive, feminine, and immune health.* Provella™ is available without a prescription, and placed behind the pharmacy counter to support the recommendations of women’s healthcare professionals and pharmacists. The List Number for Provella™ is 68025-070-30.
1. FAQ. Frequently asked questions. FAQ028. Gynecologic problems. The American College of Obstetricians and Gynecologists Web site. http://www.acog.org/~/media/ For%20Patients/faq028.pdf?dmc=1&ts=20120307T1035130561. Accessed March 7, 2012. 2. Sanz Y. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult humans. Gut Microbes. 2010;1(3):135-137. 3. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr. 2001;73(2 suppl):399S-405S. 4. BIO-Tract Delivery System [product label]. Redmond, WA: Nutraceutix, Inc. 5. Turner SJ, Hite M, Federici C. Novel design of a monolithic oral controlled-release delivery formulation for probiotic organisms. AAPS PharmSci. 2002;4(4):abstract W4200.